These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 20956322)

  • 1. Neutralization of West Nile virus by cross-linking of its surface proteins with Fab fragments of the human monoclonal antibody CR4354.
    Kaufmann B; Vogt MR; Goudsmit J; Holdaway HA; Aksyuk AA; Chipman PR; Kuhn RJ; Diamond MS; Rossmann MG
    Proc Natl Acad Sci U S A; 2010 Nov; 107(44):18950-5. PubMed ID: 20956322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. West Nile virus in complex with the Fab fragment of a neutralizing monoclonal antibody.
    Kaufmann B; Nybakken GE; Chipman PR; Zhang W; Diamond MS; Fremont DH; Kuhn RJ; Rossmann MG
    Proc Natl Acad Sci U S A; 2006 Aug; 103(33):12400-4. PubMed ID: 16895988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human monoclonal antibodies against West Nile virus induced by natural infection neutralize at a postattachment step.
    Vogt MR; Moesker B; Goudsmit J; Jongeneelen M; Austin SK; Oliphant T; Nelson S; Pierson TC; Wilschut J; Throsby M; Diamond MS
    J Virol; 2009 Jul; 83(13):6494-507. PubMed ID: 19386704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of West Nile virus neutralization by a therapeutic antibody.
    Nybakken GE; Oliphant T; Johnson S; Burke S; Diamond MS; Fremont DH
    Nature; 2005 Sep; 437(7059):764-9. PubMed ID: 16193056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A therapeutic antibody against west nile virus neutralizes infection by blocking fusion within endosomes.
    Thompson BS; Moesker B; Smit JM; Wilschut J; Diamond MS; Fremont DH
    PLoS Pathog; 2009 May; 5(5):e1000453. PubMed ID: 19478866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Fc region of an antibody impacts the neutralization of West Nile viruses in different maturation states.
    Lee PD; Mukherjee S; Edeling MA; Dowd KA; Austin SK; Manhart CJ; Diamond MS; Fremont DH; Pierson TC
    J Virol; 2013 Dec; 87(24):13729-40. PubMed ID: 24109224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-Resolution Structure Analysis of Antibody V5 and U4 Conformational Epitopes on Human Papillomavirus 16.
    Guan J; Bywaters SM; Brendle SA; Ashley RE; Makhov AM; Conway JF; Christensen ND; Hafenstein S
    Viruses; 2017 Dec; 9(12):. PubMed ID: 29211035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minute virus of mice, a parvovirus, in complex with the Fab fragment of a neutralizing monoclonal antibody.
    Kaufmann B; López-Bueno A; Mateu MG; Chipman PR; Nelson CD; Parrish CR; Almendral JM; Rossmann MG
    J Virol; 2007 Sep; 81(18):9851-8. PubMed ID: 17626084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A dynamic landscape for antibody binding modulates antibody-mediated neutralization of West Nile virus.
    Dowd KA; Jost CA; Durbin AP; Whitehead SS; Pierson TC
    PLoS Pathog; 2011 Jun; 7(6):e1002111. PubMed ID: 21738473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.
    McAuley AJ; Torres M; Plante JA; Huang CY; Bente DA; Beasley DWC
    J Virol; 2016 May; 90(9):4757-4770. PubMed ID: 26912625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Insights into Reovirus σ1 Interactions with Two Neutralizing Antibodies.
    Dietrich MH; Ogden KM; Katen SP; Reiss K; Sutherland DM; Carnahan RH; Goff M; Cooper T; Dermody TS; Stehle T
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27928010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A protective human monoclonal antibody targeting the West Nile virus E protein preferentially recognizes mature virions.
    Goo L; Debbink K; Kose N; Sapparapu G; Doyle MP; Wessel AW; Richner JM; Burgomaster KE; Larman BC; Dowd KA; Diamond MS; Crowe JE; Pierson TC
    Nat Microbiol; 2019 Jan; 4(1):71-77. PubMed ID: 30455471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody.
    Pinto D; Park YJ; Beltramello M; Walls AC; Tortorici MA; Bianchi S; Jaconi S; Culap K; Zatta F; De Marco A; Peter A; Guarino B; Spreafico R; Cameroni E; Case JB; Chen RE; Havenar-Daughton C; Snell G; Telenti A; Virgin HW; Lanzavecchia A; Diamond MS; Fink K; Veesler D; Corti D
    Nature; 2020 Jul; 583(7815):290-295. PubMed ID: 32422645
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A potent anti-dengue human antibody preferentially recognizes the conformation of E protein monomers assembled on the virus surface.
    Fibriansah G; Tan JL; Smith SA; de Alwis AR; Ng TS; Kostyuchenko VA; Ibarra KD; Wang J; Harris E; de Silva A; Crowe JE; Lok SM
    EMBO Mol Med; 2014 Mar; 6(3):358-71. PubMed ID: 24421336
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunochemical properties of West Nile virus protein prM and protein M C-end].
    Bogachek MV; Protopopova EV; Ternovoĭ VA; Kachko AV; Ivanova AV; Ivanisenko VA; Shvalov AN; Loktev VB
    Mol Biol (Mosk); 2007; 41(1):8-17. PubMed ID: 17380886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins.
    Fibriansah G; Tan JL; Smith SA; de Alwis R; Ng TS; Kostyuchenko VA; Jadi RS; Kukkaro P; de Silva AM; Crowe JE; Lok SM
    Nat Commun; 2015 Feb; 6():6341. PubMed ID: 25698059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. West Nile virus: characterization and diagnostic applications of monoclonal antibodies.
    Lelli D; Moreno A; Brocchi E; Sozzi E; Capucci L; Canelli E; Barbieri I; Zeller H; Cordioli P
    Virol J; 2012 Apr; 9():81. PubMed ID: 22500562
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A plant-produced vaccine protects mice against lethal West Nile virus infection without enhancing Zika or dengue virus infectivity.
    Lai H; Paul AM; Sun H; He J; Yang M; Bai F; Chen Q
    Vaccine; 2018 Mar; 36(14):1846-1852. PubMed ID: 29490880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The structural immunology of antibody protection against West Nile virus.
    Diamond MS; Pierson TC; Fremont DH
    Immunol Rev; 2008 Oct; 225():212-25. PubMed ID: 18837784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural and Functional Characterization of a Cross-Reactive Dengue Virus Neutralizing Antibody that Recognizes a Cryptic Epitope.
    Li J; Watterson D; Chang CW; Che XY; Li XQ; Ericsson DJ; Qiu LW; Cai JP; Chen J; Fry SR; Cheung STM; Cooper MA; Young PR; Kobe B
    Structure; 2018 Jan; 26(1):51-59.e4. PubMed ID: 29249606
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.